IRVINE, Calif.--(BUSINESS WIRE)--Quality Systems, Inc. (NASDAQ:QSII), known to its clients as NextGen Healthcare, announced today the company’s electronic health record – NextGen® Ambulatory EHR 5.9 – achieved Office of the National Coordinator for Health Information Technology (ONC-HIT) 2015 Edition Health IT Module certification from the Drummond Group, LLC, an authorized certification body (ACB).
This stamp of approval designates that NextGen Ambulatory EHR 5.9 is 2015 Edition certified electronic health record technology (CEHRT) and offers the functionality for eligible providers and hospitals to meet MIPS ACI and Meaningful Use Stage 3 requirements, qualifying these organizations to receive payments under the ongoing Quality Payment Program (QPP) and Meaningful Use (MU) EHR Incentive Programs.
“Achieving 2015 Edition certification of our NextGen Ambulatory EHR 5.9 is all about supporting our clients,” said Rusty Frantz, president and CEO, NextGen Healthcare. “Meeting our original commitments and deadlines for 2015 Edition certification means our clients not only have flexibility in 2018 for QPP and MIPS reporting – with both 2014 Edition and 2015 Edition CEHRT – but they can earn bonus incentive payments recently announced by CMS tied to exclusive use of 2015 Edition CEHRT.”
NextGen Healthcare clients and interested parties can review NextGen Ambulatory EHR 5.9 2015 Edition CEHRT details at the certified health IT product list here on the healthit.gov website.
2015 Edition Disclosure Language
This Health IT Module – NextGen Ambulatory EHR 5.9 – is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.
NextGen Ambulatory EHR 5.9 was created by NextGen Healthcare, with headquarters located at 18111 Von Karman Avenue, Irvine, CA 92612. Website is www.nextgen.com. Information about NextGen Ambulatory EHR 5.9 2015 Edition CEHRT is available from Robert Larson, Director, Product Management – robertl@nextgen.com. NextGen Ambulatory EHR 5.9 earned 2015 Edition Health IT module certification on October 25, 2017. CHPL-ID 15.04.04.2054.Next.59.01.1.171025.
About Quality Systems, Inc.
Quality Systems, Inc., known to its clients as NextGen Healthcare, provides a range of software, services, and analytic solutions to medical and dental group practices. The Company’s portfolio delivers foundational capabilities to empower physician success, enrich the patient care experience and enable the transition to value-based healthcare. Visit www.qsii.com and www.nextgen.com for additional information.
About Drummond Group, LLC
Drummond Group LLC is a global software test and certification lab that serves a wide range of vertical industries. In healthcare, Drummond Group LLC tests and certifies Controlled Substance Ordering Systems (CSOS), Electronic Prescription of Controlled Substances (EPCS) software and processes, and Electronic Health Records (EHRs) – designating the trusted test lab as the only third-party certifier of all three initiatives designed to move the industry toward a digital future. The company was founded in 1999 and is accredited for the Office of the National Coordinator Health IT Certification Program as an Authorized Certification Body (ACB) and an Authorized Test Lab (ATL). For more information, please visit http://www.drummondgroup.com.
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within the meaning of the federal securities laws, including but not limited to, statements made by Rusty Frantz, President and CEO, statements regarding certifications of the Company’s products, and other statements regarding future events, developments in the Company’s business and in the overall healthcare sector, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future. The Company cautions investors not to place undue reliance on any such forward-looking statements, which are based on information available at the time those statements are made or management's good faith belief as of that time with regard to future events, and should not be read as a guarantee of future performance or results. Risks and uncertainties exist that may cause the results to differ materially from those set forth in these forward-looking statements. Factors that could cause the anticipated results to differ from those described in the forward-looking statements and additional risks and uncertainties are set forth in Part I, Item A of our most recent Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q, including but not limited to: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; litigation and government investigations; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; disruptions caused by acquisitions of companies, products, or technologies; and general economic conditions. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
